Answers are grounded in this paper and cite their sources.
Sjögren’s syndrome (SS) is a common chronic autoimmune disease that mainly occurs in middle-aged women, manifesting as exocrine gland dysfunction and systemic complications, yet its pathogenesis remains incompletely understood, and clinical diagnosis and treatment still face great challenges. Therefore, exploring the mechanisms underlying the occurrence and development of SS is of great significance for establishing new diagnostic and therapeutic strategies. Extracellular vesicles (EVs), a type of membrane-bound vesicle that mediates intercellular communication, are rich in proteins, nucleic acids and other bioactive components and participate in the regulation of inflammation, immune response and other pathological processes. This review focuses on the biological functions of EVs and further discusses their potential value as novel biomarkers and therapeutic platforms in the clinical diagnosis and targeted treatment of SS, so as to provide a theoretical reference for the research and clinical transformation of SS. Methods: Following SANRA guidelines, PubMed, Web of Science, and Google Scholar were searched using combined keywords: Sjögren’s syndrome, primary Sjögren’s syndrome, extracellular vesicles, exosomes, biomarkers, therapeutics, with snowball screening of reference lists. We included peer-reviewed original and review articles, excluding preprints, conference abstracts and grey literature. Studies were narratively selected by relevance, quality and evidence hierarchy, without systematic review eligibility thresholds.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: